← Back to Search
Gene Therapy For Psoriasis In The K14‐VEGF Transgenic Mouse Model By Topical Transdermal Delivery Of Interleukin‐4 Using Ultradeformable Cationic Liposome
J. Li, Xia Li, Y. Zhang, X. Zhou, H. Yang, X. C. Chen, Y. Wang, Y. Q. Wei, L. Chen, H. Hu, Chang Y Liu
Published 2010 · Medicine
Download PDFAnalyze on Scholarcy
Topical transdermal gene delivery to the skin shows great potential for painless, non‐invasive administration of vaccines and therapeutic agents. Interleukin (IL)‐4 strategies have shown a good antipsoriatic effect in clinic trials. To date, no information has been acquired on the effectiveness of gene therapy for psoriasis in the K14‐VEGF transgenic mouse model by topical transdermal penetration of murine IL‐4 (mIL‐4) using ultradeformable cationic liposome (UCL).
This paper references
Efalizumab: an overview.
C. Leonardi (2003)
Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes.
J. Birchall (2000)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U. Chaudhari (2001)
The transdermal revolution.
B. J. Thomas (2004)
Skin permeation, biodistribution, and expression of topically applied plasmid DNA
Minjeong Kang (2004)
Pathogenesis and clinical features of psoriasis
C. Griffiths (2007)
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach.
K. Asadullah (1998)
with cytokine - expression plasmids induces strong antigen - specific immune responses
RW Groves (2001)
Pathogenesis and therapy of psoriasis
M. A. Lowes (2007)
The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment
Ayca Cordan Yazici (2005)
Etanercept: An overview.
B. Goffe (2003)
Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
G. Tonel (2009)
Is epidermal cell proliferation in psoriatic skin grafts on nude mice driven by T‐cell derived cytokines?
B. Baker (1992)
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
K. Ghoreschi (2003)
Endothelial leucocyte adhesion molecule‐1 (ELAM‐1) expression in cutaneous inflammation
R. Groves (1991)
Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex
A. Domashenko (2000)
Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
L. J. Liu (2001)
Overview and Evolution of Therapeutic Systems
A. Zaffaroni (1991)
Infliximab for psoriasis.
A. Gottlieb (2003)
The balance of Th1/Th2 cytokines in rheumatoid arthritis.
H. Schulze-Koops (2001)
Topical gene delivery to murine skin.
W. Yu (1999)
Discovery of transdermal penetration enhancers by high-throughput screening
P. Karande (2004)
Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
M. Rapoport (1993)
Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.
C. Ellis (2001)
Topical application of HIV DNA
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor.
C. E. Griffiths (1989)
Effects of systemic interleukin-10 therapy on psoriatic skin lesions: histologic, immunohistologic, and molecular biology findings.
K. Asadullah (2001)
Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles.
Nalini Raghavachari (2002)
Animal models of psoriasis
M. Schoen (1997)
Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.
Y. Xia (2003)
Psoriasis: advances in pathophysiology and management
A. Macdonald (2007)
Current status and future potential of transdermal drug delivery
M. Prausnitz (2004)
Psoriasis--recent advances in understanding its pathogenesis and treatment.
G. Krueger (2005)
Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma.
R. Groves (1993)
Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis
T. Patel (2004)
Development and use of alefacept to treat psoriasis.
G. Krueger (2003)
Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes.
Eun Hye Lee (2005)
In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome.
A. Kim (2004)
Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix)
S. Babiuk (2002)
This paper is referenced by
Utilization of biodegradable polymeric materials as delivery agents in dermatology
F. Rancan (2014)
Psoriasis: Molecular targets of denervation and therapy
E. M. Baerveldt (2013)
Nanoparticles for Dermal and Transdermal Delivery: Permeation Pathways and Applications
M. Foldvari (2014)
Dicationic gemini nanoparticle design for gene therapy
Mahmoud Elsabahy (2013)
[Gene therapy: nucleic acids as drugs. Action mechanisms and delivery into the cell].
B. Cavagnari (2011)
Peptide and Protein-Based Therapeutic Agents
Mary Joseph (2017)
IL-23 Induces Atopic Dermatitis-Like Inflammation Instead of Psoriasis-Like Inflammation in CCR2-Deficient Mice
S. Bromley (2013)
Hox transcription factor regulation of adult bone-marrow-derived cell behaviour during tissue repair and regeneration
Elahe Mahdipour (2011)
Gambogic acid exhibits anti-psoriatic efficacy through inhibition of angiogenesis and inflammation.
Jiaolin Wen (2014)
Lipid-mediated gene delivery to the skin.
B. Geusens (2011)
Murine models of psoriasis and its applications in drug development.
T. Luo (2019)
Delivery of biopharmaceuticals using combination of liposome and iontophoresis: a review
Santosh K Bashyal (2015)
IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine
A. Onderdijk (2015)
Perspectives on Using Nanoscale Delivery Systems in Dermatological Treatment
M. Foldvari (2015)
Transdermal Delivery of Small Interfering RNA with Elastic Cationic Liposomes in Mice
Y. Hattori (2013)
Non-viral gene therapy: Gains and challenges of non-invasive administration methods.
M. Foldvari (2016)
Liposomal delivery of proteins and peptides
Janani Swaminathan (2012)
FOR GENE THERAPY
Mahmoud Elsabahy (2013)
Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines
Yangping Wu (2015)
Development of photosensitive liposomes for the controlled release of drugs
Pranav Bhujbal (2016)
Lipid gene nanocarriers for the treatment of skin diseases: Current state‐of‐the‐art
C. Bellefroid (2019)
Antibody-mediated delivery of interleukin 4 to the neo-vasculature reduces chronic skin inflammation.
T. Hemmerle (2014)
Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation.
F. Bayat (2020)
The Dose-Dependent Tumor Targeting of Antibody–IFNγ Fusion Proteins Reveals an Unexpected Receptor-Trapping Mechanism In Vivo
T. Hemmerle (2014)
Novel topical drug carriers as a tool for treatment of psoriasis: Progress and advances
P. Suresh (2013)
Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
Jiaolin Wen (2015)
Application of nano- and micro-particles on the topical therapy of skin-related immune disorders.
Lin Sun (2015)
Cationic Liposome-Based Systems for Nucleic Acid Delivery: From the Formulation Development to Therapeutic Applications
H. Faneca (2013)
Nucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.
Michael Zakrewsky (2015)
Skin Delivery of siRNA Using Sponge Spicules in Combination with Cationic Flexible Liposomes
Xuejiao Liang (2020)
Advances in Predictive, Preventive and Personalised Medicine
S. Karabulut (2012)
This information is current as Route of Action of a Th 2 Cytokine Cells : Induces GATA 3 in Psoriatic Epidermal and IL-6 and β IL-4 Downregulates IL-1
Armanda J. Onderdijk (2015)See more